Group weighs push to switch the pill OTC
This article was originally published in The Tan Sheet
Executive SummaryA coalition of women's health experts hopes to meet with FDA "in the next few months to discuss the regulatory pathway" for a potential OTC switch of oral contraceptives. Ibis Reproductive Health, which coordinates the Oral Contraceptives Over-the-Counter Working Group, said July 9 it is interested in moving oral contraceptives OTC "as a way to increase access to ECs especially for women who now face barriers to access." Ibis said the coalition is talking with potential partners about what regulatory and research milestones must be reached to switch the prescription drugs and is working to ensure that research needed for a switch, including label comprehension and actual use studies, will address broader questions about women's access to and information about the full range of contraceptive methods. The coalition, which first met in 2004, also is working to change Medicaid policy to cover all OTC contraceptive methods
You may also be interested in...
On this week’s podcast, executive editor Shawn M. Schmitt shares expert tips and advice on how device makers can integrate the recently revised international risk management standard ISO 14971 into their quality systems.
Alpha Tau is looking to change the global radiation therapy paradigm. The Israeli start-up is developing Alpha DaRT, a novel technology for delivering alpha radiation for local tumor destruction.
Three companies are set to learn this week whether the European Medicines Agency will fast track its review of their soon-to-be-filed EU marketing applications.